-
August 13: The Week in Cancer NewsSurvival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.
by Kevin McLaughlin
-
Drug Delays Recurrence in People With Early-Stage Breast CancerPeople who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
July 30: The Week in Cancer NewsHealthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.
by Marci A. Landsmann
-
July 23: The Week in Cancer NewsTwo studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.
by Kevin McLaughlin
-
Remote CareAfter adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
July 16: The Week in Cancer NewsA study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.
by Bradley Jones
-
Moving Away From the Maximum Tolerated DoseThe FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
July 2: The Week in Cancer NewsA study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.
by Kevin McLaughlin
-
The Individual Sphere of InfluenceCan discussion of health inequities lead to actionable change?
by Marci A. Landsmann
-
From the Editor-in-Chief
The Tumor MicroenvironmentResearch is leading to treatments that target cancer's support system.
by William G. Nelson, MD, PhD
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
